Caption Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
VPM
VCM
AC
Caption Management's PTCT Position: Q3 2024 in Review
Caption Management sold out of PTC Therapeutics (PTCT) in Q3 2024, closing a stake of 6,300 shares — an estimated $193K sold.
Caption Management first reported a position in PTCT in Q2 2018 and held it in 11 quarters. The position peaked at $5.24M in Q4 2019. 202 funds tracked by Wall St. Rank hold PTCT as of Q3 2024.
- Caption Management reported no remaining PTC Therapeutics position as of Q3 2024 after selling out during the quarter.
- Caption Management sold 6,300 PTC Therapeutics shares in Q3 2024, an estimated $193K.
- Caption Management first reported a position in PTC Therapeutics in Q2 2018 and held it in 11 quarters.
- Caption Management's PTC Therapeutics position peaked at $5.24M in Q4 2019.
- 202 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2024.
Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.